LenioBio, a biotech company pioneering cell-free protein production, and Touchlight, a leader in enzymatic DNA production, have entered a supply agreement aimed at leveraging the capabilities of Touchlight’s rapid enzymatic doggybone DNA (dbDNA), to achieve unprecedented speed in vaccine development and manufacture in the context of LenioBio’s CEPI grant. Read more below: https://lnkd.in/ea4jwFRu #therapeutics #biotech #dna
Mantell Associates
Executive Search Services
City of London, England 74,153 followers
Multidiscipline Global Life Science and Pharmaceutical Headhunting Firm.
About us
Mantell Associates is a multi-discipline headhunting firm focused on providing both permanent and contract recruitment services globally, to the Biotech, Pharmaceutical, CDMO, CRO, Diagnostics, Animal Health, Consulting, Medical Device and MedTech sectors. With success ranging across C-Suite, Commercial, Technical Operations, Scientific, Clinical, Quality and Regulatory, we pride ourselves on our ability to bring the top talent to our clients, and the best opportunities to the top talent. Our services span across our Partnership Service, Contingency, Project Management and Contract models, meaning that we can cater to our client’s every requirement.
- Website
-
www.mantellassociates.com
External link for Mantell Associates
- Industry
- Executive Search Services
- Company size
- 51-200 employees
- Headquarters
- City of London, England
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Contract Development Manufacturing Organisations, Contract Manufacturing Organisations, Preclinical, Active Pharmaceutical Ingredients, Cell & Gene Therapy, Finished Dosage Forms, Biologics, Toxicology, Pharmacology, Oncology, CDMO, CMO, Biomarkers, Vaccines, Contract Research Organisation, Clinical Trial Supplies, Bioanalytics, Bioanalysis, Fine Chemicals, and Highly Potent Active Pharmaceutical Ingredients
Locations
-
Primary
150 Minories
City of London, England EC3N 1LS, GB
-
2 S Biscayne Blvd
Miami, Florida 33131, US
-
Rigistrasse 3
Zug, 6300, CH
Employees at Mantell Associates
Updates
-
Listen to what our clients and candidates have said about us... A great testimonial for George Hebden Lee, Managing Associate here at MA! "I have worked with Mantell Associates and they offer me help and support in term of career opportunities. They are really trustworthy, honest and professional. I would like to thank George George Hebden‑Lee for his support and advice during the recruitment process. He is a man of integrity and honesty." Contact George Hebden Lee on +44 (0)20 3854 7700. #testimonialtuesday #pharmarecruitment #lifesciencerecruitment
-
-
Fortrea has launched a new research and development arm aimed at creating artificial-intelligence-driven clinical trial technologies that make studies speedier, safer and more efficient. Read more below: https://lnkd.in/egQhq44w #clinicaltrials #ai #cro
Fortrea launches AI R&D arm to streamline clinical trials
fiercebiotech.com
-
Seventeen months after SK bioscience introduced its global expansion push—memorably dubbed as “SKBS 3.0”— the Korean developer and manufacturer of vaccines has acquired a 60% stake in IDT Biologika for 339 billion won ($244 million). Read more below: https://lnkd.in/ex4myCSn #acquisition #pharmaexpansion #vaccines
SK Bioscience begins 'globalization' push, paying $244M for majority stake in contract manufacturer IDT Biologika
fiercepharma.com
-
AbbVie is embracing summer’s heat, cranking up the M&A dial with the acquisition of inflammatory disease-focused Celsius Therapeutics for $250 million in cash. Read more below: https://lnkd.in/giwifdHX #acquisition #antibodies #pharmanews
AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave
fiercebiotech.com
-
New opportunity! Associate Director of Business Development - Small Molecule - East Coast. Mantell Associates is currently partnered with the CDMO arm of one of the most reputable Life Science organisations on the planet, committed to discovering innovative and vibrant ways to advance global health. You will get the opportunity to work with some of the brightest minds in the industry and join a diverse and inclusive business that offers you limitless career progression. Apply for this role directly - https://lnkd.in/enfyZWUe - or contact Onur Dilek on +44 (0)20 3854 7700. #directorjobs #smallmoleculejobs #bdjobs
-
-
David Dwamena discusses strategies for success and offers 10 ways to enhance productivity. Productivity is not just about doing more in less time; it’s about achieving better results with the time and resources available. Read more below: https://lnkd.in/ebYPzpjT #productivity #success #productivetips
10 Ways to Boost Productivity: Strategies for Success
mantellassociates.com
-
Veranova, a developer and manufacturer of specialist and complex APIs for the pharmaceutical and biotech sectors, has initiated a significant expansion of its antibody-drug conjugate (ADC) and highly potent compound development and manufacturing capabilities at its Devens, MA facility. Read more below: https://lnkd.in/ewFcGFk8 #antibodies #pharmainvestment #cdmo
Veranova to Invest $30M in Devens, MA Facility
contractpharma.com
-
Our June 'Spotlight' features Abdelaziz Toumi, PhD, MBA, CEO at Lupin Manufacturing Solutions, the newly-formed CDMO subsidiary of Lupin. Abdelaziz is a strong leader with a blend of scientific and commercial skills, bringing over two decades of experience in the biotech, pharma and CDMO sectors. He was appointed CEO of LMS earlier this month, and we look forward to following his work continuing Lupin's strong legacy! #leadership #leader #cdmo
-
-
Experts recommend that CGT manufacturers proactively design a comprehensive market access strategy early in clinical development and commercial planning timelines, ideally more than three years prior to launch. Read more below: https://lnkd.in/e6exnAas #cellandgenetherapy #marketaccess #clinical
Why early market access planning is crucial in CGT commercial strategy
fiercebiotech.com